|
1
|
Kitamura H, Kameda Y, Ito T and Hayashi H:
Atypical adenomatous hyperplasia of the lung. Implications for the
pathogenesis of peripheral lung adenocarcinoma. Am J Clin Pathol.
111:610–622. 1999.PubMed/NCBI
|
|
2
|
Henschke CI, Yankelevitz DF, Mirtcheva R,
McGuinness G, McCauley D and Miettinen OS: ELCAP Group: CT
screening for lung cancer: Frequency and significance of part-solid
and nonsolid nodules. AJR Am J Roentgenol. 178:1053–1057. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakata M, Saeki H, Takata I, Segawa Y,
Mogami H, Mandai K and Eguchi K: Focal ground-glass opacity
detected by low-dose helical CT. Chest. 121:1464–1467. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Morandi L, Asioli S, Cavazza A, Pession A
and Damiani S: Genetic relationship among atypical adenomatous
hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the
lung. Lung Cancer. 56:35–42. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kerr KM, Carey FA, King G and Lamb D:
Atypical alveolar hyperplasia: Relationship with pulmonary
adenocarcinoma, p53, and c-erbB-2 expression. J Pathol.
174:249–256. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomida S, Yatabe Y, Yanagisawa K,
Mitsudomi T and Takahashi T: Throwing new light on lung cancer
pathogenesis: Updates on three recent topics. Cancer Sci. 96:63–68.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sano T, Kitayama Y, Igarashi H, Suzuki M,
Tanioka F, Chida K, Okudela K and Sugimura H: Chromosomal numerical
abnormalities in early stage lung adenocarcinoma. Pathol Int.
56:117–125. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bettio D, Cariboni U, Venci A, Valente M,
Spaggiari P and Alloisio M: Cytogenetic findings in lung cancer
that illuminate its biological history from adenomatous hyperplasia
to bronchioalveolar carcinoma to adenocarcinoma: A case report. Exp
Ther Med. 4:1032–1034. 2012.PubMed/NCBI
|
|
9
|
Bettio D, Rizzi N, Giardino D, Persani L,
Pecori-Giraldi F, Losa M and Larizza L: Cytogenetic study of
pituitary adenomas. Cancer Genet Cytogenet. 98:131–136. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Genome Bioinformatics Group of University
of California Santa Cruz: UCSC genome browser. http://genome.ucsc.edu/cgi-bin/hgGatewayAccessed.
November 14–2014
|
|
11
|
Heighway J and Betticher DC: Lung:
Non-small cell carcinoma. Atlas of Genetics and Cytogenetics in
Oncology and Haematology. http://atlasgeneticsoncology.org/Tumors/LungNonSmallCellID5141.htmlAccessed.
November 04–2014PubMed/NCBI
|
|
12
|
Demopoulos K, Arvanitis DA, Vassilakis DA,
Siafakas NM and Spandidos DA: MYCL1, FHIT, SPARC, p16 (INK4) and
TP53 genes associated to lung cancer in idiopathic pulmonary
fibrosis. J Cell Mol Med. 6:215–222. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li MY, Lai PL, Chou YT, Chi AP, Mi YZ,
Khoo KH, Chang GD, Wu CW, Meng TC and Chen GC: Protein tyrosine
phosphatase PTPN3 inhibits lung cancer cell proliferation and
migration by promoting EGFR endocytic degradation. Oncogene.
34:3791–3803. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Su L and Liu X: Loss of CDH1
up-regulates epidermal growth factor receptor via phosphorylation
of YBX1 in non-small cell lung cancer cells. FEBS Lett.
587:3995–4000. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yun HM, Park KR, Lee HP, Lee DH, Jo M,
Shin DH, Yoon DY, Han SB and Hong JT: PRDX6 promotes lung tumor
progression via its GPx and iPLA2 activities. Free Radic Biol Med.
69:367–376. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Testa JR and Siegfried JM: Chromosome
abnormalities in human non-small cell lung cancer. Cancer Res. 52(9
Suppl): 2702s–2706s. 1992.PubMed/NCBI
|
|
17
|
Li J, Bi L, Sun Y, Lu Z, Lin Y, Bai O and
Shao H: Text mining and network analysis of molecular interaction
in non-small cell lung cancer by using natural language processing.
Mol Biol Rep. 41:8071–8079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Panani AD, Maliaga K, Babanaraki A and
Bellenis I: Numerical abnormalities of chromosome 9 and p16CDKN2A
gene deletion detected by FISH in non-small cell lung cancer.
Anticancer Res. 29:4483–4487. 2009.PubMed/NCBI
|
|
19
|
Oyanagi H, Takenaka K, Ishikawa S, Kawano
Y, Adachi Y, Ueda K, Wada H and Tanaka F: Expression of LUN gene
that encodes a novel RING finger protein is correlated with
development and progression of non-small cell lung cancer. Lung
Cancer. 46:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Meng X, Lu P, Bai H, Xiao P and Fan Q:
Transcriptional regulatory networks in human lung adenocarcinoma.
Mol Med Rep. 6:961–966. 2012.PubMed/NCBI
|
|
21
|
Testa JR, Liu Z, Feder M, Bell DW, Balsara
B, Cheng JQ and Taguchi T: Advances in the analysis of chromosome
alterations in human lung carcinomas. Cancer Genet Cytogenet.
95:20–32. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
González-Sánchez E, Martín-Caballero J,
Flores JM, Hernández-Losa J, Ángeles Ma Montero, Cortés J, Mares R,
Barbacid M and Recio JA: Lkb1 loss promotes tumor progression of
BRAF (V600E)-induced lung adenomas. PLoS One. 8:e669332013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Clark J, Freeman J and Donninger H: Loss
of RASSF2 enhances tumorigencity of lung cancer cells and confers
resistance to chemotherapy. Mol Biol Int. 2012:7059482012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Papay J, Krenacs T, Moldvay J, Stelkovics
E, Furak J, Molnar B and Kopper L: Immunophenotypic profiling of
nonsmall cell lung cancer progression using the tissue microarray
approach. Appl Immunohistochem Mol Morphol. 15:19–30. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kitaguchi S, Takeshima Y, Nishisaka T and
Inai K: Proliferative activity, p53 expression and loss of
heterozygosity on 3p, 9p and 17p in atypical adenomatous
hyperplasia of the lung. Hiroshima J Med Sci. 47:17–25.
1998.PubMed/NCBI
|
|
26
|
Kohno H, Hiroshima K, Toyozaki T, Fujisawa
T and Ohwada H: p53 mutation and allelic loss of chromosome 3p, 9p
of preneoplastic lesions in patients with nonsmall cell lung
carcinoma. Cancer. 85:341–347. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamasaki M, Takeshima Y, Fujii S,
Kitaguchi S, Matsuura M, Tagawa K and Inai K: Correlation between
genetic alterations and histopathological subtypes in
bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia
of the lung. Pathol Int. 50:778–785. 2000. View Article : Google Scholar : PubMed/NCBI
|
